Saturday 17 October 2026
Export MMSI’s income statement to Excel — free account
Merit Medical Systems, Inc.
MMSI Healthcare Medical Instruments & Supplies
Merit Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 9.51%, EPS grew 18.2%, free cash flow fell 25.7% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
89.20
0.37
−0.41%
Follow MMSI
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
40.62 | 46.72 | 46.57 | 53.13 | 72.44 | 0.00 | 346.89 | 69.76 | 73.81 | 58.22 |
Piotroski F-Score |
7 | 6 | 6 | 7 | 7 | 3 | 5 | 4 | 7 | 5 |
P/S ratio |
3.44 | 4.15 | 3.50 | 3.44 | 3.25 | 3.19 | 1.73 | 3.30 | 2.92 | 1.93 |
Altman Z-Score |
4.42 | 4.78 | 3.87 | 6.13 | 4.75 | 3.67 | 2.35 | 3.71 | 4.28 | 2.98 |
P/FCF ratio |
24.53 | 30.81 | 40.56 | 59.77 | 29.77 | 26.52 | 0.00 | 144.04 | 98.64 | 62.67 |
Altman Z″-Score (non-manufacturers) |
4.93 | 4.68 | 4.84 | 4.82 | 3.82 | 3.09 | 3.00 | 3.43 | 3.96 | 3.52 |
Beneish M-Score |
(2.70) | (2.46) | (2.90) | (2.52) | (2.70) | (2.98) | (2.59) | (2.30) | (2.30) | (2.58) |
P/Operating CF |
52.93 | 81.91 | 70.66 | 141.16 | 76.35 | 83.36 | 63.90 | 123.21 | 109.93 | 67.41 |
P/B ratio |
3.29 | 4.08 | 3.66 | 3.45 | 3.36 | 3.21 | 1.81 | 3.13 | 3.14 | 2.34 |
Price to Tangible BV |
9.66 | 13.48 | 8.91 | 7.77 | 9.75 | 13.55 | 11.35 | 21.67 | 10.08 | 11.23 |
EV/Sales |
3.63 | 4.41 | 3.69 | 3.56 | 3.42 | 3.50 | 2.13 | 3.68 | 3.26 | 2.43 |
EV/EBITDA |
16.94 | 21.61 | 20.45 | 22.71 | 23.37 | 31.89 | 17.57 | 25.19 | 27.20 | 18.49 |
EV/Operating CF |
18.51 | 27.12 | 31.96 | 35.81 | 24.95 | 20.40 | 27.18 | 37.50 | 37.81 | 27.40 |
EV/FCF |
25.90 | 32.76 | 42.77 | 61.88 | 31.26 | 29.06 | (765.05) | 160.22 | 110.06 | 79.12 |
Quick Ratio |
2.82 | 2.72 | 3.83 | 1.09 | 1.03 | 1.18 | 1.19 | 1.26 | 1.31 | 1.23 |
Current Ratio |
4.34 | 4.27 | 5.45 | 2.40 | 2.04 | 2.32 | 2.50 | 2.45 | 2.73 | 2.76 |
Net Debt/EBITDA |
0.89 | 1.27 | 1.04 | 0.77 | 1.11 | 2.78 | 3.28 | 2.54 | 2.82 | 3.84 |
Debt/Assets |
27.33% | 30.16% | 35.39% | 11.90% | 14.73% | 21.10% | 25.01% | 24.39% | 25.05% | 34.41% |
Debt/Equity |
0.46 | 0.53 | 0.68 | 0.17 | 0.23 | 0.37 | 0.46 | 0.42 | 0.41 | 0.65 |
Asset Turnover |
0.59 | 0.57 | 0.63 | 0.70 | 0.65 | 0.56 | 0.59 | 0.65 | 0.71 | 0.70 |
Operating CF/Net income |
2.31 | 1.83 | 1.54 | 1.53 | 3.04 | (16.79) | 14.28 | 2.06 | 2.28 | 2.66 |
Capex/Depreciation |
(0.61) | (0.31) | (0.36) | (0.52) | (0.31) | (0.46) | (0.77) | (0.94) | (0.76) | (0.79) |
Interest Coverage |
6.98 | 4.99 | 7.99 | 13.81 | 11.58 | (0.16) | 1.24 | 5.66 | 4.27 | 3.96 |
| 8.67% | 9.33% | 8.05% | 6.82% | 4.85% | (1.03%) | 0.58% | 5.22% | 4.69% | 4.17% | |
| 5.03% | 5.07% | 4.73% | 4.50% | 2.93% | (0.58%) | 0.32% | 3.08% | 2.68% | 2.34% | |
ROIC |
6.17% | 5.62% | 5.39% | 4.26% | 3.13% | (0.08%) | 0.72% | 2.91% | 2.24% | 2.71% |
Return on Tangible Assets |
10.46% | 11.01% | 7.33% | 10.78% | 7.85% | (1.57%) | 0.84% | 7.17% | 5.58% | 4.66% |
Average Days of Receivables |
55.03 | 57.16 | 56.11 | 57.83 | 59.90 | 61.21 | 63.11 | 63.52 | 59.88 | 53.87 |
Research and Development Expense of Revenue |
6.42% | 6.45% | 6.58% | 6.56% | 6.63% | 5.97% | 6.60% | 6.74% | 7.06% | 7.49% |
Selling, General and Administrative Expense of Revenue |
30.03% | 29.47% | 29.72% | 29.76% | 31.23% | 30.89% | 32.90% | 31.27% | 31.48% | 30.54% |
Intangible Assets out of Total Assets |
0.39 | 0.40 | 0.30 | 0.38 | 0.41 | 0.44 | 0.45 | 0.49 | 0.42 | 0.42 |
Share Based Compensation of Revenue |
2.87% | 2.10% | 1.70% | 1.57% | 1.50% | 1.49% | 0.94% | 0.69% | 0.56% | 0.42% |
Graham Net Nets |
(0.01) | (0.02) | 0.00 | 0.00 | (0.04) | (0.09) | (0.21) | (0.09) | (0.06) | (0.17) |
Graham Number |
36.16 | 33.22 | 27.75 | 24.37 | 18.93 | 0.00 | 5.91 | 17.92 | 13.56 | 10.66 |
Earnings Yield |
2.46% | 2.14% | 2.15% | 1.88% | 1.38% | (0.31%) | 0.29% | 1.43% | 1.35% | 1.72% |
Free Cash Flow Yield |
4.08% | 3.25% | 2.47% | 1.67% | 3.36% | 3.77% | (0.16%) | 0.69% | 1.01% | 1.60% |
Revenue per Share |
25.62 | 23.30 | 21.83 | 20.26 | 19.14 | 17.39 | 18.06 | 16.89 | 14.91 | 13.60 |
Operating CF per Share |
5.03 | 3.79 | 2.52 | 2.01 | 2.62 | 2.98 | 1.41 | 1.66 | 1.29 | 1.21 |
Capex per Share |
(1.43) | (0.65) | (0.64) | (0.85) | (0.53) | (0.89) | (1.46) | (1.27) | (0.84) | (0.79) |
Free Cash Flow per Share |
3.59 | 3.14 | 1.88 | 1.16 | 2.09 | 2.09 | (0.05) | 0.39 | 0.44 | 0.42 |
Cash per Share |
7.55 | 6.47 | 10.19 | 1.03 | 1.21 | 1.03 | 0.80 | 1.29 | 0.66 | 0.43 |
Shareholders Equity per Share |
26.78 | 23.69 | 20.87 | 20.15 | 18.52 | 17.29 | 17.25 | 17.85 | 13.86 | 11.22 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
26.78 | 23.69 | 20.87 | 20.15 | 18.52 | 17.29 | 17.25 | 17.85 | 13.86 | 11.22 |
Free Cash Flow |
212.54 | 182.76 | 108.45 | 66.15 | 117.50 | 116.04 | (2.76) | 20.25 | 21.55 | 18.56 |
Working Capital |
800.39 | 707.37 | 904.91 | 308.44 | 245.93 | 244.70 | 272.88 | 254.49 | 200.50 | 155.09 |
Capital Expenditures |
(84.84) | (38.04) | (36.70) | (48.14) | (29.74) | (49.23) | (80.58) | (66.28) | (41.18) | (35.03) |
Net Current Asset Value |
(61.46) | (115.47) | (14.77) | 9.52 | (126.28) | (276.11) | (352.84) | (257.40) | (119.36) | (201.19) |
EV/EBIT |
29.80 | 38.46 | 37.43 | 46.75 | 60.29 | 0.00 | 137.01 | 55.36 | 71.72 | 42.11 |
Capex to Sales |
0.06 | 0.03 | 0.03 | 0.04 | 0.03 | 0.05 | 0.08 | 0.08 | 0.06 | 0.06 |
Price to Operating Income |
28.23 | 36.17 | 35.49 | 45.15 | 57.42 | 0.00 | 111.41 | 49.77 | 64.27 | 33.36 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.33 | 0.31 | 0.27 | 0.24 | 0.26 | 0.28 | 0.28 | 0.21 | 0.18 | 0.16 |
Cash ROIC |
7.69% | 7.35% | 4.15% | 4.72% | 8.70% | 8.49% | (0.19%) | 1.45% | 2.18% | 2.21% |
Accounts Receivable Turnover |
6.87 | 6.69 | 6.69 | 6.42 | 6.36 | 5.78 | 6.11 | 6.47 | 6.98 | 7.09 |
Accounts Payable Turnover |
12.05 | 10.61 | 10.02 | 10.18 | 11.18 | 10.77 | 10.35 | 10.97 | 12.25 | 9.88 |
Inventory Turnover |
2.43 | 2.34 | 2.36 | 2.59 | 2.81 | 2.66 | 2.66 | 2.77 | 2.91 | 2.99 |
Average Days of Payables |
28.42 | 35.06 | 35.74 | 39.57 | 34.45 | 32.33 | 35.45 | 40.41 | 31.75 | 32.99 |
Days of Inventory on Hand |
156.63 | 156.64 | 164.68 | 153.65 | 137.43 | 128.45 | 146.46 | 147.75 | 141.14 | 130.02 |
Average Receivables |
220.50 | 202.86 | 187.82 | 179.38 | 169.02 | 166.84 | 162.82 | 136.51 | 104.26 | 85.14 |
Average Payables |
64.53 | 67.22 | 67.22 | 62.06 | 52.73 | 52.23 | 54.32 | 44.48 | 32.78 | 34.30 |
Average Inventory |
319.88 | 304.97 | 284.93 | 243.96 | 209.97 | 211.86 | 211.62 | 176.41 | 137.99 | 113.35 |
Average Assets |
2,552.26 | 2,371.92 | 1,994.61 | 1,656.13 | 1,656.35 | 1,710.86 | 1,688.67 | 1,365.91 | 1,027.31 | 860.77 |
Average Common Equity |
1,481.83 | 1,290.68 | 1,173.20 | 1,092.10 | 999.19 | 954.26 | 941.36 | 804.55 | 587.26 | 482.15 |
Columns are period end dates